Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Asset Writedowns and Impairment (2016 - 2020)

Harvard Bioscience (HBIO) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with $787000.0 as the latest value for Q4 2020.

  • Quarterly Asset Writedowns and Impairment rose 367.69% to $787000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $791000.0 through Dec 2020, down 45.64% year-over-year, with the annual reading at $787000.0 for FY2020, 687.0% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2020 was $787000.0 at Harvard Bioscience, up from $4000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $941000.0 in Q2 2019, with the low at -$294000.0 in Q4 2019.
  • Average Asset Writedowns and Impairment over 5 years is $207285.7, with a median of $28000.0 recorded in 2017.
  • Peak annual rise in Asset Writedowns and Impairment hit 6860.0% in 2019, while the deepest fall reached 1276.0% in 2019.
  • Over 5 years, Asset Writedowns and Impairment stood at $676000.0 in 2016, then plummeted by 116.27% to -$110000.0 in 2017, then soared by 122.73% to $25000.0 in 2018, then crashed by 1276.0% to -$294000.0 in 2019, then skyrocketed by 367.69% to $787000.0 in 2020.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $787000.0, $4000.0, and -$294000.0 for Q4 2020, Q1 2020, and Q4 2019 respectively.